SCHEMBL5218101

SCHEMBL5218101

O=C(O)C(Cc1ccccc1)N1C(=O)C(=Cc2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)SC1=S

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 5/20 1.00
MAPT P10636 6/20 0.72
KMT2A Q03164 4/20 0.72
MEN1 O00255 3/20 0.72
POLB P06746 2/20 0.72
MAPK1 P28482 1/20 0.72
RECQL P46063 1/20 0.72
BCL2 P10415 5/20 0.71
BCL2L2 Q92843 5/20 0.71
BAD Q92934 5/20 0.71
PTPN1 P18031 1/20 0.70
MME P08473 2/20 0.69
PLA2G1B P04054 1/20 0.69
ATG4B Q9Y4P1 1/20 0.69
ALDH1A1 P00352 3/20 0.69
CRHBP P24387 1/20 0.68
CRHR2 Q13324 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
APAF1 O14727 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3054451 0.87 ADAMTS5 (0.77) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL6888325 0.86 ADAMTS5 (0.76) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL6888323 0.86 ADAMTS5 (0.76) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL19430434 0.84 MAPT (1.00) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL13846498 0.83 MAPT (0.87) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL7149409 0.81 ADAMTS5 (0.68) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL245003 0.81 ADAMTS5 (1.00) ADAMTS5PTPN1
SCHEMBL186520 0.81 ADAMTS5 (1.00) ADAMTS5PTPN1
SCHEMBL3638794 0.80 MAPT (0.82) ADAMTS5MAPTKMT2AMEN1POLB
SCHEMBL12678079 0.80 MAPT (0.82) ADAMTS5MAPTKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313471-B1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS UCB SA (BE) 2007-04-11 EP disclosed
US-7105554-B2 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2006-09-12 US disclosed
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD (GB) 2004-01-08 US disclosed
EP-1313471-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS Oxford GlycoSciences (UK) Limited (GB) 2003-05-28 EP disclosed
WO-2002017915-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS OXFORD GLYCOSCIENCES (UK) LIMITED (GB) 2002-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents SLC5A2, OXSR1, SLC5A1 ADAMTS5 4556/4885MAPT 4658/4885KMT2A 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.